A new clinical trial is investigating sublingual edaravone to treat cognitive decline caused by Cerebral Small Vessel Disease (CSVD). This study targets oxidative stress in brain blood vessels, offering a … Read More
The post New Sublingual Edaravone Trial for CSVD Cognitive Decline appeared first on Archyde.